Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.08

-2.9%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (14828)	12/21/2004 9:21:26 PM
From: John Metcalf	Read Replies (1) of 52153

"The other Big Picture winners in the short run might be the insurance companies - United Health and the like." Well, OK. So the insurance companies avoid paying for some drugs for pain. With the pain no longer made tolerable by medicines, patients go to their doctors to find, and treat, the causes of pain. Then -- diagnosis, surgery, more expensive targeted medicines. At the end of the day, do insurers come out ahead? Partly being argumentative, Peter; heuristically so, I hope. Personally, I have never understood the insurance industry's reluctance to pay for the cheapest treatment modality.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next